Iovance Biotherapeutics Inc., of San Carlos, Calif., appointed Friedrich Graf Finckenstein chief medical officer.

Adverum Biotechnologies Inc., of Menlo Park, Calif., appointed Carol Hoang vice president, medical affairs and James Shahbazian vice president, finance.

Ideaya Biosciences Inc., of South San Francisco, appointed Paul A. Stone chief financial officer, Andres Briseno, vice president, finance and Mick O'Quigley vice president, development operations.

Biocryst Pharmaceuticals Inc., of Research Triangle Park, N.C., appointed Megan Sniecinski chief business officer.